CanSino Biologics Inc. ( CASBF) - Key Metrics
CASBF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.45 | $0.16 | -$0.02 | -$0.13 |
| 2026Q1 | $0.76 | -$0.16 | -$0.23 | -$0.36 |
| 2025Q4 | $1.42 | $0.05 | $0.28 | $0.03 |
| 2025Q3 | $1.25 | $0.11 | $0.13 | -$0.06 |
| 2025Q2 | $0.79 | -$0.01 | $0.08 | -$0.14 |
CASBF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 27.56 |
| 2026Q1 | 0% | -41.60 |
| 2025Q4 | 0% | 162.48 |
| 2025Q3 | 0% | 106.78 |
| 2025Q2 | -638.80% | -909.60 |
CASBF
Price: $3.35
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.02 USD
P/E Ratio: 230
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.4 billion